Prognostic Effect of KELIM Score of Prostate‐Specific Antigen in Hormone‐Sensitive Prostate Cancer Patients Treated With Novel Androgen Receptor Inhibitors: Pioneering New Ways
These findings suggest that the PRO-KELIM score can be a valuable prognostic tool in the mCSPC to assess early treatment response and predict disease progression.
Authors
- Hacer Demir (ORCID: https://orcid.org/0000-0003-1235-9363)
- Onur Yazdan Balçık (ORCID: https://orcid.org/0000-0002-3386-2075)
- Semiha Urvay (ORCID: https://orcid.org/0000-0002-0181-3842)
- Yusuf İlhan (ORCID: https://orcid.org/0000-0002-2875-6876)
- Muslih Ürün (ORCID: https://orcid.org/0000-0002-9883-3398)
- Özden Özilice (ORCID: https://orcid.org/0000-0003-3568-728X)
- Murat Araz (ORCID: https://orcid.org/0000-0002-4632-9501)
- İsmail Beypınar (ORCID: https://orcid.org/0000-0002-0853-4096)
- Berrak Mermit Erçek (ORCID: https://orcid.org/0000-0003-1058-5500)
- Ali Fuat Gürbüz (ORCID: https://orcid.org/0000-0003-1455-471X)
- Coşkun Yıldız (ORCID: https://orcid.org/0000-0003-1834-7216)
Institutions
- Van Yüzüncü Yıl Üniversitesi (TR)
- Necmettin Erbakan University (TR)
- Antalya Eğitim ve Araştırma Hastanesi (TR)
- Alanya University (TR)
- Kayseri Eğitim ve Araştırma Hastanesi (TR)
- Department of Public Health (MM)
- Antalya IVF (TR)
- Afyonkarahisar Sağlık Bilimleri Üniversitesi
- Afyon Kocatepe University (TR)
Publication Details
- Journal
- The Prostate
- Published
- 2025-11-23
- DOI
- https://doi.org/10.1002/pros.70098
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00